The clinical case
What is happening to
your body — and what
nutritional oncology offers
Cancer creates specific biological vulnerabilities that standard nutrition was not designed to address. Understanding them is the foundation for understanding why Nutrovene exists.
Nutritional oncology. Built for what cancer does.
The gap
Why “eat well and maintain weight” is necessary but not sufficient
Standard dietary advice in oncology is valuable. But it was built for a model of malnutrition that does not fully account for what makes cancer-related malnutrition different. In cancer, weight loss and muscle wasting are driven by cytokine-mediated catabolism — a state the cancer itself generates — not inadequate intake.
The MTHFR problem
Up to 40% of people carry a genetic variation preventing them from converting standard B-vitamins into active forms their cells can use. Standard supplements — and dietary B-vitamins — do not work for these patients. Active-form vitamins bypass this entirely.
Gut absorption under treatment
Standard mineral supplements use inorganic salt forms that absorb adequately in a healthy gut but poorly in a damaged one. Chelated mineral forms maintain absorption even when chemotherapy has compromised gut integrity.
Cancer-related fatigue is cellular
CRF is driven by mitochondrial dysfunction, NAD+ depletion, and carnitine deficiency — not tiredness. It cannot be addressed by rest or calories. Specific nutrients with specific mechanisms are required.
Vitamin D across all treatments
60–90% of patients are vitamin D insufficient at diagnosis. D3 regulates immune function, cell differentiation, and inflammation — relevant regardless of treatment type. D3 in CWS form absorbs even in fat malabsorption.
Your experience, explained
What you are going through — and what addresses it
What you experience
What is causing it
What Nutrovene addresses
Quality of life — a primary outcome
Surviving treatment and living through it are different goals
Quality of life is a primary clinical outcome in oncology — measured, reported in trials, and increasingly used in treatment evaluation. Nutritional status is one of its strongest independent predictors.
Prehabilitation
The nutritional foundation before treatment is the most underutilised quality of life intervention in oncology. Patients who enter treatment nutritionally prepared experience less severe side effects, maintain independence longer, and have more energy for the people and things that matter.
Active treatment
Addressing the biological drivers of fatigue, muscle loss, and gut disruption allows patients to remain more present in their own lives — not just surviving appointments but working, being with family, and feeling like themselves between them.
Survivorship
Persistent fatigue affects 30–40% of survivors for years after treatment. Quality of life recovery is often slower than clinical recovery. The clinical system has frequently moved on. Nutrovene has not.
“Cancer is a lonely journey.”
The appointments, the waiting rooms, the side effects, the information coming at you from every direction — and underneath it all, the very human experience of trying to keep going while your body and your life feel uncertain in ways they never have before.
Nutritional support during cancer is not only about surviving treatment. It is about living through it — maintaining the energy to be present with the people who matter, the strength to do the things that still bring meaning, the capacity to feel like yourself even when your body is under extraordinary pressure.
And it is about the quality of the life you build afterwards. Your quality of life throughout this journey matters. Nutrovene was designed with that in mind.